NCT07869901 Sleep and Circadian Rhythm Intervention in ICU
| NCT ID | NCT07869901 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Shanghai Zhongshan Hospital |
| Condition | ICU Hospitalization |
| Study Type | INTERVENTIONAL |
| Enrollment | 70 participants |
| Start Date | 2026-08-01 |
| Primary Completion | 2027-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 70 participants in total. It began in 2026-08-01 with a primary completion date of 2027-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Intensive care unit (ICU) patients are frequently exposed to various stressors that contribute to severe sleep disruption and circadian rhythm disturbances. Growing evidence suggests that circadian rhythm disruption plays a critical role in the development of multiple adverse outcomes in critically ill patients. Therefore, implementing interventions that prioritize the maintenance of normal circadian, sleep, and behavioral patterns may represent an important strategy to improve outcomes in ICU patients.
Eligibility Criteria
Inclusion Criteria: * Adult patients aged 18 years or older. * Patients expected to stay in the surgical ICU for at least 2 nights. * Patients directly admitted to the surgical ICU postoperatively. * Patients with a Richmond Agitation-Sedation Scale (RASS) score between -1 and 1 upon ICU admission. Exclusion Criteria: * Patients who have delirium or dementia at ICU admission. * Patients who are unable to communicate effectively. * Patients with hearing or vision impairment. * Patients with lower-limb deep vein thrombosis, fractures, or multiple severe injuries that contraindicate early mobilization. * Patients after cranial or otolaryngological surgery who cannot use earplugs or eye masks. * Patients with a history of dementia, psychiatric disorders, or structural neurological diseases. * Pregnant or breastfeeding patients. * Patients in a terminal or end-of-life condition.
Frequently Asked Questions
Who can join the NCT07869901 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying ICU Hospitalization. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07869901 currently recruiting?
Yes, NCT07869901 is actively recruiting participants. Visit ClinicalTrials.gov or contact Shanghai Zhongshan Hospital to inquire about joining.
Where is the NCT07869901 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT07869901 clinical trial?
NCT07869901 is sponsored by Shanghai Zhongshan Hospital. The trial plans to enroll 70 participants.